FULCRUM THERA (FULC)
$3.31
0.07 (2.11%)
FULC Stock Quote Delayed 30 Minutes
FULC Stock Earnings: Fulcrum Therapeutics Beats EPS for Q1 2024
FULC stock results show that Fulcrum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$3.59
Market Cap
193.79M
PE Ratio
-0.08
EPS
-41.4525
Volume (Avg. Vol.)
702,429
Day's Range
$3.10 - $3.62
52-Week Range
$2.86 - $13.70
Dividend & Yield
N/A (N/A)
